Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 30,000 shares at $94.64 ($2.9M) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Scheduled sale ($2.9M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.64 | 2,602 | $246K | 8.6% |
| 2 | $95.34 | 16,595 | $1.6M | 55.0% |
| 3 | $96.15 | 6,926 | $666K | 23.2% |
| 4 | $97.56 | 1,973 | $192K | 6.7% |
| 5 | $98.20 | 1,021 | $100K | 3.5% |
| 6 | $99.66 | 883 |
| $88K |
| 3.1% |
| Total | $95.84 avg | 30,000 | $2.9M | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |
| MIRM | SELL | 2026-02-03 | $941K | — | Filing → |